A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared with Pulmicort Flexhaler (ELBRUS)

Trial Identifier:	D6930C00011
Sponsor:	AstraZeneca
NCTID::	NCT03934333
Start Date:	May 2019
Primary Completion Date:	September 2019
Study Completion Date:	September 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MD	Baltimore, MD, United States of America, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.